CpG DNA augments the immunogenicity of plasmid DNA vaccines.
Klinman
D M
DM
Section of Retroviral Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.
Ishii
K J
KJ
Verthelyi
D
D
D000818:Animals; D018899:CpG Islands / Q000276:immunology*; D004247:DNA / Q000276:immunology*; D005818:Genetic Engineering; D005822:Genetic Vectors / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D009838:Oligodeoxyribonucleotides / Q000276:immunology; D010047:Ovalbumin / Q000276:immunology; D010957:Plasmids / Q000276:immunology*; D019444:Vaccines, DNA / Q000276:immunology*
D009838:Oligodeoxyribonucleotides; D019444:Vaccines, DNA; D010047:Ovalbumin; D004247:DNA